Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.
| Image |  |
|---|---|
| Description | scientific article published on 26 May 2009 |
| Author/s |
author: Gilles Montalescot Keith Fox Robert A Harrington Jose Luis López-Sendón Moreno Shaun G Goodman Freek Verheugt John H. Alexander Mikhail Ruda Deepak L. Bhatt Steen E Husted Lars Wallentin Mikael Dellborg Frank Cools Witold Rużyłło Puneet Mohan Richard C Becker |
| Publication date | May 26, 2009 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |